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Open access under Cwas quantiﬁed for at least 8 weeks post-SCI using the
Hargreaves test. We found that SCI rats consuming the pre-
ventive O3PUFA-enriched diet exhibited a signiﬁcant reduc-
tion in thermal hyperalgesia compared to those consuming
the normal diet. Functional neurometabolomic proﬁling
revealedadistinctivederegulation in themetabolismof endo-
cannabinoids (eCB) and relatedN-acyl ethanolamines (NAEs)
at 8 weeks post-SCI. We found that O3PUFAs consumption
led to a robust accumulation of novel NAE precursors,
including the glycerophospho-containing docosahexaenoyl
ethanolamine (DHEA), docosapentaenoyl ethanolamine
(DPEA), and eicosapentaenoyl ethanolamine (EPEA). The tis-
sue levels of these metabolites were signiﬁcantly correlated
with the antihyperalgesic phenotype. In addition, rats con-
suming the O3PUFA-rich diet showed reduced sprouting of
nociceptive ﬁbers containing CGRP and dorsal horn neuron
p38 mitogen-activated protein kinase (MAPK) expression,
well-established biomarkers of pain. The spinal cord levels
of inositols were positively correlated with thermal hyperal-
gesia, supporting their role as biomarkers of chronic
neuropathic pain. Notably, the O3PUFA-rich dietary interven-
tion reduced the levels of these metabolites. Collectively,
these results demonstrate the prophylactic value of dietary
O3PUFA against SCI-mediated chronic pain.
 2013 The Authors. Published by Elsevier Ltd.
Key words: DHA, EPA, dietary fatty acids, endocannabinoid
metabolome, spinal cord injury, chronic pain.
INTRODUCTION
Chronic neuropathic pain is one of the most important
determinants in the perceived quality of life of spinal
cord injury (SCI) patients (Anderson, 2004).
Unfortunately, current therapeutics to treat this condition
lack necessary eﬃcacy and are limited in scope by
unwanted side eﬀects and poor tolerance. These
shortcomings could be partly overcome with the use of
preventive approaches that can provide resilience to
damage prior to irreversible biochemical alterations
occur in the perturbed cord. Trauma to the spinal cord
triggers a robust secondary pathophysiological
response, leading to cell death, inﬂammation, and
dysfunction (Hulsebosch, 2002; Norenberg et al., 2004).
Neuroinﬂammation is regarded as a hallmark
mechanism underlying injury progression and pain
processing (Christensen and Hulsebosch, 1997a;
Hulsebosch et al., 2009), and thus represents an
attractive target for therapeutic strategies (Kwon et al.,
2011a,b).
Open access under CC BY-NC-SA license.C BY-NC-SA license.
2 J. D. Figueroa et al. / Neuroscience 255 (2013) 1–18Dietary-essential omega-3 polyunsaturated fatty acids
(O3PUFAs), such as docosahexaenoic acid (DHA), are
integral components of neural membrane phospholipids
and play crucial roles in anti-inﬂammatory responses
(Calder, 2008). Longstanding studies have
demonstrated that dietary PUFAs are mediating factors
in pain processing, as evidenced by increased threshold
for thermal pain and neuropathic pain in rats fed with
high omega-3 to omega-6 PUFA ratios (Yehuda and
Carasso, 1993). Recent studies have shown that
O3PUFAs and their derivatives can exert strong
antinociceptive eﬀects against thermal and chemical
stimulation in various animal models (Nakamoto et al.,
2010; Xu et al., 2010; Tokuyama and Nakamoto, 2011).
Given this evidence, it would seem reasonable to
consider that dietary O3PUFAs may also play important
roles in SCI-induced pain.
In a recent report, we showed that SCI causes a
robust PUFA deregulation and leads to a marked DHA
deﬁciency, which was associated with impaired recovery
and dysfunction (Figueroa et al., 2013). Notably,
administration of O3PUFAs maintained the cord PUFA
homeostasis, conferred neuroprotection, prevented
dysfunction and facilitated recovery after acute and
chronic SCI, even when administered in a prophylactic
manner (Figueroa et al., 2012, 2013). These ﬁndings led
us to hypothesize that a preventive diet enriched in
O3PUFAs modulates behavioral responses implicated in
pathological nociception in rats. This idea is supported
by studies showing that the diet type at the time of
injury can aﬀect pain behaviors associated with nerve
lesions (Shir and Seltzer, 2001; Alloui et al., 2003;
Hargraves and Hentall, 2005; Li et al., 2005; Estebe
et al., 2006). Despite this evidence, diet remains a
largely unexplored therapeutic avenue to ameliorate
pain in SCI.
This study is an initial attempt to assess the eﬀects of
dietary O3PUFAs on thermal pain stimuli in SCI rats.
Because N-acylated ethanolamines (NAE) and related
endocannabinoids (eCBs) are bioactive lipids implicated
in pain processing (Beltramo et al., 2006; Petrosino et al.,
2007; Hama and Sagen, 2011), we focused on identifying
the involvement of dietary O3PUFAs in their local
modulation following SCI. Here, the eCB metabolome
has been expanded to include the ethanolamines,
glycerides, and metabolic precursors, intermediates, and
derivatives. These metabolites have been implicated in
regulating anti-inﬂammatory responses and can exert
cannabimimetic actions as endogenous agonists of
cannabinoid receptors (Devane et al., 1992; Hanus et al.,
1993; Priller et al., 1995; Brown et al., 2010), but whether
dietary PUFAs impact the levels of these bioactive lipids
in SCI has not been comprehensively evaluated. To
address this issue, we employed both LC/MS and GC/
MS-based metabolomics on cord samples collected from
sham and contusion SCI-operated Sprague–Dawley rats
that received either control or O3PUFA-enriched diets.
Deciphering the neurometabolomic proﬁle that
distinguishes pain-like behaviors may have important
clinical implications for pain management and allow for
improved prognosis in SCI.EXPERIMENTAL PROCEDURES
Animals
All animal studies were performed in compliance with the
Loma Linda University School of Medicine regulations
and institutional guidelines consistent with the NIH
Guide for the Care and Use of Laboratory Animals.
Female Sprague–Dawley rats were received from
Charles River Laboratories (Portage, MI) and housed in
individual cages on alternating 12-h light/ dark cycles. It
is worth noting that in this study we used two
independent cohorts of animals. Although both cohorts
received the same dietary and surgical interventions,
and behavioral testing, there were diﬀerences in the
time allowed for survival (cohort 1: at least four animals
per diet group, allowed to survive until 12 weeks post-
injury; cohort 2: at least 13 animals per diet group,
allowed to survive until 8 weeks post-injury). Animals in
cohort 2 were also used to determine the eﬀect of
dietary O3PUFAs in sensorimotor and autonomic
dysfunction after SCI (Figueroa et al., 2013).Diet composition
Custom AIN-93-based diets were prepared with
modiﬁcations to the fat composition as described
previously (Figueroa et al., 2013). Brieﬂy, dietary fats
were approximately 6% of the pellets dry weight and
were supplied as either soybean oil (control chow) or
menhaden ﬁsh oil (O3PUFA-enriched chow:
DHA= 12.82-gm and EPA = 6.91-gm per 100 gm of
diet). Diets were matched for cholesterol content.Surgical and post-operative procedures
Eight weeks after the dietary pretreatment, animals were
deeply anesthetized with a mixture of ketamine/xylazine
(80 and 10 mg/kg, respectively). The spinal cord injuries
were generated using the well-characterized New York
University (NYU) Impactor (Gruner, 1992). Notably,
trauma caused using this device induces below-level
pain that is well developed and longstanding, suggesting
that the model is suitable for chronic pain research
(Jung et al., 2008). To produce the contusion, the skin
and the muscles overlying the spinal column were cut. A
laminectomy was performed at the T9–T10 level and
the T8 and T12 spinal processes were clamped to the
Impactor, and the exposed dorsal surface of the cord
was subjected to weight drop impact using a 10-g rod
released from a height of 12.5-mm. Sham animals
received only a laminectomy. The animals body
temperature was maintained at 37 C during the
procedure. After operation, muscle layers were sutured
and skin layers closed. The bladders of injured rats
were expressed using the Crede’s maneuver three
times a day until voiding reﬂexes were restored.
Cefazolin (Bristol Myers Squibb, New York, NY; 25 mg/
kg, s.q.) and Buprenex (buprenorphine; Reckett and
Colman Pharmaceuticals, Inc. Richmond, VA; 0.05 mg/
kg, s.c.) were given to all rats for 5 and 3 consecutive
days, respectively. Animals were allowed to survive for
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dissected for metabolomics and immunohistochemical
analyses, respectively.
Nociceptive testing
Thermal hyperalgesia (TH) was assessed using the well-
established Hargreaves withdrawal test to thermal
noxious stimulus (Hargreaves et al., 1988). This
behavior has been found to be a sensitive and
reproducible behavioral test to investigate chronic
neuropathic pain and is exhibited approximately 28 days
following contusion injury (Resnick et al., 2004;
DomBourian et al., 2006; Rajpal et al., 2007; Cramer
et al., 2008). In the week prior to the baseline
recordings, the animals were habituated to the
behavioral testing apparatus by undergoing ﬁve diﬀerent
daily testing sessions. Once plantar paw placement was
re-established, rats were evaluated weekly until animals
were euthanized. Brieﬂy, the animals were placed in a
Plexiglas enclosure that rested on an elevated glass
ﬂoor (Plantar Test, UGO BASILE, Biological Research
Apparatus, Comerio, Italy). After allowing the animals to
acclimate to the chamber for 30 min, a movable focused
infrared emitter was placed under the animal’s paw. A
photocell automatically turned the emitter oﬀ when the
animal moved its paw and the latency time for the
animal to withdraw its paw was recorded. Strength of
stimulation was adjusted to produce hindpaw baseline
latencies close to 12 s (approximately 50–60 C). A
safety cutoﬀ of 20 s was used to prevent prolonged
exposure to the noxious heat. Five diﬀerent trials were
performed per paw with at least 5 min allowed between
each trial. The instrument operators were blinded to the
treatment assignations. Minimum and maximum latency
values were excluded from each paw analysis at each
time point.
It is well-recognized that the testing season, the
climate (humidity and temperature), the time of day, the
cage density, the animal weight, the locomotor behavior,
the number of instrument operators, and order of testing
have a signiﬁcant impact on the results of pain studies
in rodents (Mogil et al., 2000; Mogil and McCarson,
2000; Le Bars et al., 2001; Chesler et al., 2002).
Furthermore, the repetitive nature of the Hargreaves
test makes it very susceptible to learning phenomena
(Kocevski and Tvrdeic´, 2008). Dietary lipids, including
DHA, are known modulators of learning and
sensitization processes, which could introduce
unwanted confounding eﬀects and aﬀect the outcome of
sensory results (Ikemoto et al., 2001; Hashimoto et al.,
2002; Lim et al., 2005; McNamara et al., 2008; Joseph
et al., 2012). On the basis of this evidence and to
facilitate data interpretation, the thermal latencies are
represented as percent change from the baseline and
were normalized to changes observed in sham animals
as previously reported (Figueroa et al., 2013). Brieﬂy,
the nociceptive phenotype was determined by the
following equation:
HWL% ¼ ½ðHWLib  HWLixÞ=HWLib  ½ðHWLsb
 HWLsxÞ=HWLsbð100Þ ð1ÞHWL%= hindpaw withdrawal latency percent change from
baseline normalized to week-to-week changes in sham animals;
ib = latency from injured animal in diet A at baseline;
ix = latency from injured animal in diet A at time x;
sb = averaged latency from all sham animals in diet A at
baseline; sx = averaged latency from all sham animals in diet A
at time x.Metabolomic proﬁling
Unbiased metabolic proﬁling was performed as
previously described (Figueroa et al., 2013). Animals
were deeply anesthetized and transcardially perfused
with ice-cold PBS to limit blood contamination. Spinal
cord samples (75–100 mg) were ﬂash frozen in liquid
nitrogen and immediately stored at 80 C. Samples
were homogenized in water at the time of analyses.
The protein was precipitated with methanol containing
four standards to report on extraction eﬃciency. The
resulting supernatant was split into equal aliquots for
analysis on the three platforms. Aliquots were dried
under nitrogen and vacuum-desiccated. The
metabolomics proﬁling platform employed for this
analysis was based on a combination of three
independent platforms: ultrahigh performance liquid
chromatography/tandem mass spectrometry (UHPLC/
MS/MS2) optimized for basic species, UHPLC/MS/MS2
optimized for acidic species, and gas chromatography/
mass spectrometry (GC/MS). Controls were analyzed
concomitantly with the experimental samples. For
instance, aliquots of a well-characterized human
plasma pool served as technical replicates throughout
the data set, extracted water samples served as
process blanks, and a cocktail of standards spiked into
every analyzed sample allowed instrument
performance monitoring. Experimental samples and
controls were randomized across platform run days.
The metabolites were identiﬁed by automated
comparison of the ion features in the experimental
samples and compared to a reference library of
chemical standard entries that included retention time,
molecular weight (m/z), preferred adducts, and in-
source fragments as well as associated MS spectra.
The neurometabolomics features were curated by
visual inspection for quality control using software
developed at Metabolon (Dehaven et al., 2010).
Archived mass spectrometry data from our previously
reported study, which was curated for only identiﬁed
‘named’ compounds in Metabolon’s chemical reference
library (Figueroa et al., 2013), was re-curated to
further investigate the unidentiﬁed compounds that
were detected in the study.
Of particular importance, inositols’ features have
been implicated as osmolytes and clinical metabolic
markers of inﬂammation (Brand et al., 1993;
Schuhmann et al., 2003), SCI-mediated chronic pain
(Pattany et al., 2002), and recently as a marker of SCI
progression (Erschbamer et al., 2011). Since SCI-
induced edema and water disturbances may introduce
bias in the quantiﬁcation of osmolytes, the relative
levels of Ins were quantiﬁed relative to creatine levels
(Ins/Cr ratio).
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An estimate of the false discovery rate (FDR), which is
given by the q-value, was calculated to take into
account the multiple comparisons that normally occur in
metabolomic-based studies as previously reported
(Storey and Tibshirani, 2003b,a). For example, when
analyzing 200 compounds, it is expected to see about
10 compounds meeting the p 6 0.05 cut-oﬀ by random
chance. Thus, the q-value describes the false discovery
rate; a low q-value (q< 0.10) is an indication of high
conﬁdence in a result.
The partial least square-discriminant analysis
(PLS-DA) is a supervised method that uses multivariate
regression techniques to extract via linear combination
of original variables (X) the information that can predict
the class membership (Y). This regression was
performed using the plsr function provided by R pls
package. The classiﬁcation and cross-validation were
performed using the corresponding wrapper function
oﬀered by the caret package. To assess the signiﬁcance
of class discrimination, prediction accuracy during
training and the separation distance permutation test
were performed. In each permutation, a PLS-DA model
was built between the data (X) and the permuted class
labels (Y) using the optimal number of components
determined by cross validation for the model based on
the original class assignment. The variable importance
in projection (VIP), which is a weighted sum of squares
of the PLS loadings and takes into account the amount
of explained Y-variation in each dimension was used to
measure the impact of each metabolite in the model.
Generally, features with high impact have VIP values
higher than 1.Immunodetection
Immunoﬂuorescence methods have been described
previously (Figueroa et al., 2012). Brieﬂy, spinal cord
sections were dried at room temperature for 10–15 min,
washed with PBS, and post-ﬁxed with 4% PFA for
10 min. The sections were blocked and incubated at
4 C ON in 20% normal donkey serum with 0.1%
Tween-20 with rabbit anti-phosphorylated-p38, p-p38
(1:200; R&D Systems, Minneapolis, MN) and mouse
anti-NeuN monoclonal antibody (1:250; Millipore,
Billerca, MA). Additional experiments used mouse anti-
CD11b (OX42, 1:100; AbD Serotec, Raleigh, NC) to
examine reactive microglial cells. Alternatively, sections
were incubated with rabbit anti-GAP43 (1:500; Abcam,
Cambridge, MA) and sheep polyclonal calcitonin gene-
related peptide (CGRP; 1:500; Abcam). The sections
were then washed with PBS and incubated in secondary
antibodies [Alexa Fluor 594-conjugated donkey anti–
rabbit or donkey anti-sheep (1:500; Invitrogen, Carlsbad,
CA) and Alexa Fluor 488-conjugated donkey anti–
mouse or donkey anti-rabbit (1:500; Invitrogen)].
Primary antibody omission and normal serum controls
were used to conﬁrm the speciﬁcity of the
immunoreaction. Slides were examined with an
Olympus Optical Fluoview FV1000 confocal microscope.
Unbiased stereological methods were followed aspreviously reported (Figueroa et al., 2012). Two blinded
observers quantiﬁed the immunoreactivity in lamina I to
III, which were identiﬁed by superimposing photomi-
crographs with spinal cord diagrams from the Watson,
Paxinos, and Kayalioglu spinal cord atlas. For each
animal, the p-p38-positive neurons were counted
manually in at least four randomly selected areas of the
superﬁcial dorsal horns. The mean number of p-p38-
expressing neurons was then tabulated for each
animal and group. For ﬁber-sprouting analyses, the
CGRP-GAP43 double-labeling immunoreactivity was
quantitated by inverting merged images into black
(marker-positive) and white in the NIH Image J program
for measurement of positive pixels/area in the dorsal
horns laminae I to III. Results were obtained by
averaging measurements made by blinded investigators.Statistical analysis
Statistical analyses were performed using SPSS version
20.0 (IBM: SPSS, Armonk, New York), Prism 5 software
v5d (GraphPad Software Inc., San Diego, CA), the ‘‘R’’
program (http://cran.r-project.org/), and metaboanalyst
(Xia et al., 2009, 2012). Two-Way Analysis of Variance
(ANOVA) followed by Bonferroni post hoc comparisons
was used to determine the eﬀect of the diet type, injury,
and time on hindpaw thermal withdrawal latencies and
diﬀerences within and between groups. To determine
the antinociceptive eﬀects of dietary O3PUFAs in time
we calculated the area under the nociception versus
time curve (AUC) and subjected AUCs to t-tests as
previously described (Svensson et al., 2005; Buczynski
et al., 2010; Morisseau et al., 2010). ANOVA contrasts
were used to identify features that diﬀered signiﬁcantly
between tested groups. All other data were assessed by
Mann–Whitney U test. The Kolmogorov–Smirnov and
Shapiro–Wilk normality tests together with the Grubbs’
method, also known as ESD (extreme studentized
deviate; www.graphpad.com), were used to investigate
outliers and spread. Spearman’s rank correlation tests
were used to explore associations between detected
metabolites and the sensory phenotype. Data are
presented as mean ± SEM. Statistical diﬀerences were
considered signiﬁcant at p< 0.05 unless otherwise
speciﬁed.RESULTS
General conditions and summary of previously
published ﬁndings related to this study
Previously, we reported that experimental spinal cord
injury (SCI) leads to a marked docosahexaenoic acid
(DHA) deﬁciency and motor and autonomic deﬁcits,
which were corrected by dietary omega-3
polyunsaturated fatty acids (O3PUFAs) prophylaxis
(Figueroa et al., 2013). Here, we hypothesized that this
dietary prophylactic intervention would reduce thermal
hypersensitivity in SCI. We characterized the
antihyperalgesic eﬀects of this dietary strategy and
investigated the extent to which dietary O3PUFAs
impact the levels of bioactive metabolites and cellular
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the injured cord.Preventive dietary O3PUFAs attenuate the
development of below-level thermal hyperalgesia
after injury to the spinal cord
To examine the eﬀect of dietary O3PUFAs on the onset
and maintenance of neuropathic pain after SCI, we used
the paw thermal sensitivity to noxious heat (Hargreaves
testing). We found no diﬀerences in the average
baseline hindpaw withdrawal latencies between
groups (10.61 ± 0.59 s for control-fed animals and
11.34 ± 0.44 s for animals receiving O3PUFA diets;
mean ± SEM, p> 0.05). Because of diﬀerences in
survival times and missing data points between animal
cohorts, we used two-way ANOVA to identify the eﬀect
of the diet type and operation in the thermal latencies
diﬀerences. We found that both diet type and the
surgical intervention were signiﬁcant sources of variation
in our data set [for the diet eﬀect F(3,49253) = 40.22,
p= 0.0001, n= 8–18 rats per group]. Post hoc
analysis revealed signiﬁcant diﬀerences in thermal
thresholds between sham and injured animals receiving
control diets from week 8 to week 12 post-operation
(p< 0.05). A novel ﬁnding of this study is that the
animals consuming diets rich in O3PUFAs showed no
signiﬁcant alterations in their hindpaw withdrawal
latencies when compared to their sham counterparts
(p> 0.05). Post hoc comparisons between injured
groups revealed that the most signiﬁcant diﬀerences in
nociception occurred between after 7 wpi and hence the
focus period of this current investigation (p< 0.05;
Fig. 1A). Sham-operated rats receiving O3PUFA-richFig. 1. Responsiveness to thermal stimulation in animals receiving control a
leads to below-level thermal hyperalgesia in animals receiving control diets. H
are plotted versus time (weeks post-injury, wpi). For each timepoint, the ind
observed in sham animals receiving the same diet using Eq. (1) (see ‘Expe
observed between sham animals. Notably, dietary O3PUFAs prevented the
sham animals). TW-ANOVA identiﬁed the diet type and surgery as signiﬁcant
n= 8–18]. Bonferroni’s post hoc analyses showed signiﬁcant thermal withdr
diﬀerent diet types (p< 0.05). (B) To investigate the overall eﬀect of O3
generated using the area under the curve (AUC). Analyses of the AUC rev
(Mann-Whitney U rank test; p< 0.001). Each bar represents mean ± SEM;diets did not show signiﬁcant changes in their thermal
thresholds when compared to animals being fed with
control diets (p> 0.05).
Calculation of the area under the thermal withdrawal
latency change versus time curve (AUC) showed a
potent antihyperalgesic eﬀect of dietary O3PUFAs in
SCI rats (Fig. 1B; Mann–Whitney U rank test
p= 0.0008; n= 18).Metabolomic proﬁling reveals distinctive
endocannabinoid signatures associated with chronic
SCI and dietary O3PUFAs
We used an untargeted metabolomics approach
(Figueroa et al., 2013) to investigate the neurochemical
consequences of O3PUFAs consumption on the endo-
cannabinoid (eCB) metabolome. Fig. 2A summarizes
the four groups analyzed in this study and the
metabolomic interactions between them. A total of 275
named metabolites and 76 unnamed biochemicals were
detected and analyzed. The diet rich in O3PUFA
signiﬁcantly changed more than 20% of the detected
metabolic features (74 total altered features: 40
upregulated, 34 downregulated when compared to
animals receiving control diets). Of signiﬁcance, more
than 40% of these altered metabolites were associated
with the endocannabinoid metabolome and are the
focus of the present study. In this study, data were
protected against false positives using the false
discovery rate q value. We ﬁrst sorted the metabolomic
data by the p-value and chose the cutoﬀ for signiﬁcance
at p< 0.05. We found that the false discovery rate of
various diet-derived metabolites with signiﬁcant p values
were extremely low (q< 0.1%) when comparing injurednd O3PUFA-enriched diets. (A) Thoracic contusion to the spinal cord
indpaw withdrawal latencies (averaged percent change from baseline)
ividual latencies were adjusted to the percent change from baseline
rimental Procedures’ section). No signiﬁcant latency alterations were
development of thermal hyperalgesia (p> 0.05 when compared to
sources of variation [for diet/surgery F(3,49253) = 40.22, p= 0.0001,
awal latency changes when comparing injured animals receiving the
PUFA in thermal hindpaw sensitivities, the hyperalgesic index was
ealed that the O3PUFA diet had a signiﬁcant antihyperalgesic eﬀect
n= 18.
Fig. 2. SCI and dietary O3PUFAs modulate the endocannabinoid-related neurometabolome. (A) Venn diagram depicting the numerical interactions
among data sets. ANOVA contrast analyses were used to evaluate the regulation pattern diﬀerences between groups. The total number of features
detected across 36 spinal cord tissue samples was 351 metabolites. Diagram illustrates the number of total metabolites signiﬁcantly altered
between groups (e.g., O3PUFA diet SCI/Control diet SCI contrast resulted in 60 signiﬁcantly altered metabolites; 38 upregulated and 22
downregulated; p< 0.05). (B) Partial least square discriminant analysis (PLS-DA) distinguished subgroups based on dietary intake at 8 weeks
post-injury (wpi). Model was constructed using scaled intensity peaks of the detected features associated with the endocannabinoids (eCBs)
system: classic eCBs, eCBs glycerols, and related N-acyl ethanolamines (NAEs) and metabolites. Projections provided statistically signiﬁcant
separations between subgroups.
Fig. 3. PLS-DA model validation and metabolite impact. (A) Prediction accuracy training permutation test validate the PLS-DA model by showing a
signiﬁcant observed statistic (p< 0.01). (B) The variable inﬂuence on projection (VIP) analyses, which reﬂect the importance of metabolites showed
the signiﬁcant contribution of selective NAEs, endocannabinoids, endocannabinoid glycerols, and O3PUFA-derived glycerophospho ethanolamines
(GP-NAEs) in our PLS model. The colored boxes on the right indicate the relative concentrations of the corresponding metabolite in each group
under study. Abbreviations: GP, glycerophospho; EPEA, eicosapentaenoyl ethanolamine; DPEA, docosapentaenoyl ethanolamine; AEA,
arachidonoyl ethanolamine; EG, eicosenoyl glycerol; LEA, linoleoyl ethanolamine; 2-AG, 2-arachidonoyl glycerol; 2-PG, 2-palmitoyl glycerol; 1-
OG, 1-oleoyl glycerol; PEA, palmitoyl ethanolamine. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
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below).
The partial least square-discriminant analysis
(PLS-DA) score plot was obtained using the variationscores of the ﬁrst two principal components, component
1 (22.7%) and component 2 (44.5%). These analyses
revealed distinctive endocannabinoid-related proﬁles
between groups (Fig. 2B). Each plot mark corresponds
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metabolite levels detected for that animal. Hotelling’s T2
conﬁdence ellipse, at a signiﬁcance level of 0.05,
showed no outliers. Permutation analyses validated the
class discrimination and neurometabolomic separation
(observed test statistic p< 0.01). Consequently, more
than 67% (component 1 + component 2) of the
metabolomics diﬀerences can be explained with
certainty by the generated PLS model. For simplicity,
only the prediction accuracy during training result is
shown (Fig. 3A).
We found that both chronic SCI and the preventive
diet enriched in O3PUFAs had a signiﬁcant impact in
the levels of acyl glycerol class endocannabinoids and
in the metabolism of N-acyl ethanolamines (Fig. 3B).
Also, the cord of injured animals receiving the
O3PUFAs showed higher levels of eicosenoyl, palmitoyl,
arachidonoyl, and oleoyl glycerols when compared to
control-fed injured animals. In general, the diet rich in
O3PUFAs skewed the metabolomic proﬁle toward
increased levels of long-chain N-acyl ethanolamines. In
particular, we identiﬁed a selective group of
glycerophospho-containing N-acyl ethanolamines (GP-
NAEs). These molecules showed the strongestFig. 4. Chronic O3PUFAs consumption leads to a robust accumulation of
Box and whiskers graphs illustrate a marked increase in the levels of O3PUF
group). (B) Potential metabolic pathways for the biosynthesis of NAEs. This
Cravatt, 2006, 2008). Reaction 1 is mediated by an NAPE-selective phospho
Recent studies suggest the involvement of a novel phospholipase A/B, named
2 and 3). The secretory PLA2 can also release fatty acid from sn-2 p
glycerophosphodiesterase, GDE1. Lyso-PLD catalyzes reaction 5. Abbrevia
noyl ethanolamine; EPEA, eicosapentaenoyl ethanolamine; GP, glycero
ethanolamine; G3P, glycerol-3-phosphate; LPA, lyso-phosphatidic acid; PA,inﬂuence (highest variable importance in projection, VIP,
values) to the observed metabolomics diﬀerences
between groups.Dietary O3PUFA leads to a marked accumulation of
diet-derived N-acyl ethanolamine (NAEs) precursors
The beneﬁcial neurological eﬀects of O3PUFAs are partly
related to their anti-inﬂammatory properties, however the
exact mechanisms behind these actions are unknown. A
putative mechanism could be via their conversion to
related N-acyl ethanolamines (NAEs). Here, we present
new evidence demonstrating the signiﬁcant impact of
diet in the regulation of these bioactive lipids after
chronic SCI. In agreement with previous studies (Wood
et al., 2010), we found that dietary O3PUFAs lead to a
robust accumulation N-acyl ethanolamines
glycerophospholipids containing DHA, DPA, and EPA
fatty acids (Fig. 4A). Interestingly, metabolomic analysis
revealed very low abundance of these lipids in the cord
of animals receiving control diets.
Fig. 4B illustrates the current knowledge on the NAEs
biosynthetic pathways (Simon and Cravatt, 2006,
2008). Brieﬂy, it has been proposed that NAEs arediet-derived glycerophospho ethanolamines in the spinal cord. (A)
A-dervied GP-NAEs (relative to the median metabolite levels in each
illustration is adapted and modiﬁed from previous reports (Simon and
lipase D (PLD). Pathways 2-3-4 and 2-5 are NAPE-PLD independent.
Abh4, a-b-hydrolase 4 in the NAPE conversion to GP-NAE (reactions
osition of NAPE (reaction 2). Reaction 4 is catalyzed by a new
tions: DHEA, docosahexaenoyl ethanolamine; DPEA, docosapentae-
phospho, NAE, N-acyl ethanolamine; NAPE, N-acyl phosphatidyl
phosphatidic acid.
Table 1. The endocannabinoid (eCB) metabolome is altered following chronic SCI and inﬂuenced by dietary O3PUFAs. ANOVA contrasts were
performed to determine statistical diﬀerences in metabolite relative amounts (diﬀerences were considered signiﬁcant when p< 0.05; n= 8 rats per
sham group and 10 rats per injury group). Comparisons were made between the four studied groups: (1) sham control diet, (2) SCI control diet, (3)
sham O3PUFA-rich diet, and (4) SCI O3PUFA-rich diet. Notably, in spinal cord injured animals, the O3PUFA diet decreased the levels of the
glycerophospho 2-LEA and 2-AEA and dramatically increased the levels of O3PUFA-derived GP-NAEs. Numbers represent fold of change. Heat map
color legend: red, signiﬁcant increase; green, signiﬁcant decrease; light red and green represent marginal statistical signiﬁcance. Abbreviations: LEA,
linoleyl ethanolamine; AEA, arachidonoyl ethanolamine; GP-NAEs, glycerophospho n-acyl ethanolamines
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ethanolamines (NAPEs) through a single NAPE-PLD-
dependent pathway (NAPE-PLD). Alternatively, NAPE-
PLD-independent multi-step processes have been
recently reported and involve alpha/beta-hydrolase 4
(ABDH4 or Abh4) and the glycerophosphodiesterase,
GDE1. The results presented herein suggest a marked
activation of NAPE-PLD-independent pathways following
chronic SCI.
The eﬀects of the diet and chronic SCI on the detected
metabolites associated with the endocannabinoid and
related NAEs are summarized in Table 1. ANOVA
contrasts were performed to determine statistical
diﬀerences in metabolite relative amounts between groups
(diﬀerences were considered signiﬁcant when p< 0.05;
n=at least 8 rats per group). The false discovery rate
showed very low q-values for features associated with thediet-derived O3PUFAs (EPEA= 8  1015; DPEA=
2.40 109; DHEA= 0.012), supporting the signiﬁcance
of the observations.
Spearman’s correlation analyses were used to
explore the linear trends between cord metabolite levels
and changes in thermal thresholds. The relative levels
of NAEs containing 22 carbon N-acyl chains and the
glycerophospho NAEs of O3PUFAs were positively
correlated with reduced thermal withdrawal latency
changes (Fig. 5A–D; Spearman r values > 0.50;
p< 0.05). We also found a signiﬁcant positive
correlation between the relative levels of palmitoyl
ethanolamine (PEA) and non-hyperalgesic responses,
supporting its anti-inﬂammatory roles in SCI (Esposito
et al., 2011; Esposito and Cuzzocrea, 2012). Together,
our ﬁndings suggest that these diet-derived metabolites
may play signiﬁcant roles in antinociception.
Fig. 5. Metabolic features correlated with pain-like phenotypes. Scatter plot shows the signiﬁcant relationship between the levels of (A)
ethanolamines containing 22-carbon N-acyl chains, (B) GP-DHEA, (C) GP-DPEA, (D) PEA and the hindpaw thermal withdrawal latency change
from baseline. For every correlation, the Spearman r was higher than 0.50, with a p< 0.05, XY = 20 pairs.
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biosynthetic pathways in SCI-induced neuropathic
pain
The biochemical basis and etiology underlying chronic
neuropathic pain remains poorly understood and has
limited the development of eﬀective interventions. To
characterize the unique lipidomic changes underlying
neuropathic pain-like behaviors after contusive SCI, we
ﬁrst used the K-means clustering method to assign the
animals to three groups according to their thermal
threshold changes (Fig. 6A). This partitioning method
identiﬁed a group of animals that showed no signiﬁcant
alterations in their thermal threshold (normal behavior,
non-hyperalgesic; p> 0.05). Another cluster was shown
to exhibit signiﬁcantly reduced latencies when compared
to their baseline values (hyperalgesic behavior;
p< 0.05). The algorithm also identiﬁed animals with
increased thermal latencies at 8 wpi when compared to
baseline values (hypoalgesic behavior; p< 0.05). The
mean baseline values did not diﬀer signiﬁcantly between
clustered groups (p> 0.05), demonstrating that the
diﬀerent phenotypes developed after SCI.
Notably, the glycerophospho N-acyl ethanolamines
(GP-NAEs) derived from the O3PUFA-rich diet were the
most relevant metabolites for explaining the diﬀerences
between non-hyperalgesic and hyperalgesic animals(Fig. 6B). The metabolomics analyses revealed
decreased levels of the O3PUFA-derived GP-NAEs in
the hyperalgesic animals, suggesting a potential role for
these in neuropathic pain.
Although additional factors contribute to the
development of pain following SCI, it is well established
that the extent of cord damage is a major determinant
(Lindsey et al., 2000; Yezierski, 2000). To determine the
relative contribution of tissue spared to the observed
metabolomics diﬀerences, we assessed the cord
damage between the animals exhibiting thermal
hyperalgesia and those showing no signiﬁcant
diﬀerences in paw withdrawal thresholds when
compared to baseline values (p> 0.05). Because the
spinal cords were used for metabolomics studies, we
could not determine the extent of injury using
stereological techniques. However, the Basso, Beattie
and Bresnahan (BBB) locomotor score provides a
reliable indirect measure of the injury magnitude (Basso
et al., 1996). We found that the BBB locomotor scores
were not signiﬁcantly diﬀerent between clustered
groups, indicating that the extent of injury (and repair)
was similar (p> 0.05; Fig. 6C). This observation
validates that additional processes such as chronic
neuroinﬂammation and hyperexcitability play major roles
in pathological nociception after SCI.
Fig. 6. (A) K-means clustering divided animals based on their nociceptive behavior (D latency = latencyendpoint  latencybaseline). A group of
animals exhibited no signiﬁcant D latency changes at endpoint (‘‘normal’’ or non-hyperalgesic cluster). The clustering algorithm identiﬁed two
additional groups: hyperalgesic rats (signiﬁcant D latency decrease at endpoint) and hypoalgesic (increased D latency at endpoint). Data are
presented as mean ± SEM. Data were analyzed by TW-ANOVA followed by Bonferroni’s post hoc: ns, not signiﬁcant; (⁄) = p< 0.05;
(⁄⁄⁄⁄) = p< 0.0001. (B) Metabolomic analyses using the normal and hyperalgesic clusters conﬁrmed the potential role of the NAE metabolism in
pain processing after SCI. In particular, the O3PUFA-derived NAEs were shown to have a signiﬁcant impact in the metabolic diﬀerences observed
between thermal pain behaviors. Notably, the animals showing hyperalgesic phenotypes exhibited reduced levels of these metabolites.
Abbreviations: X-11204, unnamed compound which has been tentatively identiﬁed as an unsaturated hydroxyl fatty acid with an empirical formula of
C13H24O3; GP, glycerophospho; OEA, oleoyl ethanolamine; DHEA, docosahexanoyl ethanolamine; DPEA, docosapentaenoyl ethanolamine; EPEA,
eicosapentaenoyl ethanolamine. (C) Basso, Beattie and Bresnahan locomotor scores measured in hyperalgesic (n= 6) and non-hyperalgesic
(n= 13) rats. Repeated measures ANOVA did not identify pain classiﬁcation (non-hyperalgesia versus hyperalgesia) as a signiﬁcant contributor of
the total variance (p> 0.05). Pain classiﬁcation accounted for 1.54% of the total variance (after adjusting for matching) with a p value of 0.2669. F
statistics (1,66.88) = 1.318, indicating that the extent of the injury was similar in both groups. To determine whether the mean diﬀerences were
more apparent, the data were analyzed using the Mann–Whitney U t-test at the time points showing greatest diﬀerence. The analysis revealed a p
value of 0.2005 at 4 weeks post-injury, which can be interpreted as no reason to reject the null hypothesis. In other words, the locomotor score
distributions of both dietary groups are identical at 4 wpi. This observation proposes underlying neurochemical mechanisms that may be
independent of the injury severity and to the amount of spared tissue. Data represent mean ± SEM.
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reduced levels of p38 mitogen-activated protein
kinase (MAPK) expression in dorsal horn neurons
following SCI
To examine the anti-inﬂammatory eﬀects of the O3PUFA-
enriched diet, we determined the mRNA levels of key
cytokines, chemokines, and receptors that have been
associated with inﬂammatory pain (e.g., IL-1b, IL-6, TNF-
a, CCL2, CCR2, CX3CL1, and CX3CR1). We found that
the O3PUFA diet did not reduce the mRNA levels of
these pro-inﬂammatory factors in below-level cord
segments when compared to control-fed animals at 8 wpi
(p> 0.05; data not shown). Histological analysesshowed no signiﬁcant diﬀerences in the dorsal horn
immunoreactivity (IR) to OX42 between treatment groups
(Fig. 7A–C). These results do not contradict the well-
established roles of dietary O3PUFAs but rather suggest
that these anti-inﬂammatory eﬀects may occur during the
initial inﬂammatory trigger in a time- and context-
dependent manner. This observation also points to the
involvement of additional mechanisms. For instance,
although we did not observe signiﬁcant diﬀerences in the
expression of these biomarkers, qualitative diﬀerences
were noticeable in cell morphology. In particular, we
found microglia with morphological features typically
implicated in activated states in the spinal cords of
Fig. 7. Dietary O3PUFA did not reduce microglial cell immunoreactivity in superﬁcial dorsal horns following chronic SCI. Representative images
from OX42 immunoreacted spinal cord injured caudal sections from animals receiving control (A) or O3PUFA (B) diets. Quantitative analyses
showed no signiﬁcant changes in inﬂammatory markers immunoreactivity between treatment groups in the dorsal horn laminae I–III at 12 weeks
post-injury (C). Closer examination revealed that following chronic SCI, spinal microglia displayed hypertrophied cell bodies and thick processes,
which are characteristic of their activated state (D). Interestingly, some animals treated with dietary O3PUFA showed microglial cells with small
soma containing thin and radial projecting processes (resting state of microglia, E). Scale bar = A–B, 200 lm; D–E, 20 lm. The arrows indicate
OX42-positive cell somata. Dietary O3PUFA-derived GP-NAEs levels are potentially implicated in anti-inﬂammatory responses. (F) A scatter plot
shows the relationship between the levels of the O3PUFA-derived GP-NAEs (O3DGP-NAEs) and the total inositol-to-creatine levels (Ins/Cr). The
Spearman r= 0.68, CI(0.83 to 0.44), p= 0.0001, XY = 18 pairs include sham and injury-operated animals fed with control diet. (G)
Preventive administration of dietary O3PUFAs resulted in a signiﬁcant reduction in the Ins levels (Mann–Whitney U test, ⁄⁄⁄⁄p< 0.0001, n= 10).
Data represent mean ± SEM.
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bodies and thick processes) (Fig. 7D). Interestingly, a
few animals receiving the preventive dietary intervention
rich in O3PUFAs exhibited microglial cells with small
soma containing thin and radially projecting processes
(Fig. 7E), conﬁrming previous observations on the DHA-
elicited immunomodulatory eﬀects in microglia (Ebert
et al., 2009).
Because LC/MS and GC/MS-based metabolomics
provide a more sensitive method to assess inﬂammatory
biomarkers, we measured the levels of inositol (Ins; see
‘Experimental procedures’). Interestingly, the averaged
relative levels of the major omega-3 PUFA-derived GP-
NAEs were negatively associated with Ins relative levels
(Spearman r= 0.68, p< 0.0001; Fig. 7A). Further,
dietary O3PUFAs signiﬁcantly reduced the cord Ins
levels (Fig. 7B; p< 0.0001, n= 10). Altogether, thesedata support an anti-inﬂammatory and antinociceptive
role for O3PUFAs in chronic SCI.
A number of pharmacological studies implicate the
spinal p38 mitogen-activated protein kinase, p38 MAPK,
as one important underlying mechanism of nociception
and neuronal hyperexcitability in SCI (Crown et al.,
2008; Gwak et al., 2009). Here, we used
immunohistochemistry to examine the expression of this
established pain biomarker in rats treated with dietary
O3PUFAs relative to animals receiving control diets. We
found that the cords of animals receiving O3PUFAs had
decreased phosphorylated p38-positive neurons in the
superﬁcial dorsal horns relative to controls at 12 wpi
(Fig. 8A–G; p< 0.05; n= at least 4 animals). Not
surprisingly, we found a signiﬁcant positive correlation
between the expression levels of neuronal p-p38 MAPK
and the hyperalgesic behaviors (data not shown).
Fig. 8. Preventive dietary O3PUFAs reduce the expression of phosphorylated p38 in below-level dorsal horn neurons. At 12 weeks post-injury,
laser confocal microscopic evaluation revealed dorsal NeuN-positive neurons (A) containing the phosphorylated p38 mitogen-activated protein
kinase (MAPK) (B). Merged photomicrographs (C) and inset (D) show distinctive neuronal subpopulations expressing this inﬂammatory marker after
chronic SCI. Dorsal horn photomicrographs show noticeable diﬀerences in the number of p-p38-containing neurons when comparing dietary groups
(control = E versus O3PUFA= F). (G) Manual cell counts conﬁrmed that the dietary O3PUFA intervention signiﬁcantly reduced the percent of
NeuN-positive cells expressing p-p38 MAPK in below-level dorsal horn superﬁcial laminae (p< 0.05; n= at least 4 animals). Scale bars = A–C
and E–F, 100 lm; D, 20 lm.
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containing ﬁbers in chronic SCI
The growth-associated protein 43 (GAP43) and calcitonin
gene-related peptide (CGRP) have been widely used as
biomarkers of nociceptive ﬁber sprouting and
neuropathic pain (Nahin et al., 1994; Christensen and
Hulsebosch, 1997b; Ondarza et al., 2003). Thus, we
tested whether the preventive O3PUFA-enriched diet
reduces the sprouting of CGRP-containing primary
aﬀerents following chronic SCI. Laser confocal
microscopy showed CGRP and GAP43 colocalization in
spinal cord sections obtained from regions 3–5 mm
caudal to the injury site (Fig. 9A). CGRP (Fig. 9B, F)
and GAP43 (Fig. 9C, G) labeled photomicrographs from
animals receiving control chow (Fig. 9B–E) or O3PUFA-
rich (Fig. 9F–I) diets were merged (Fig. 9D, H) and
subsequently converted to binary format to facilitate
automated analyses (Fig. 9E, I). Quantitative double-
labeling immunoﬂuerescence revealed decreased
sprouting of CGRP-positive primary aﬀerents at 12 wpi
(Mann–Whitney U test p< 0.05, n= at least 4 animals)
(Fig. 9J).DISCUSSION
This study shows that a preventive diet rich in omega-3
polyunsaturated fatty acids (O3PUFAs) reduces thermal
hyperalgesia in rats experiencing chronic spinal cord
injury (SCI). This antihyperalgesic eﬀect was directlycorrelated with the levels of a series of novel
glycerophospho ethanolamines containing O3PUFA acyl
chains. The anti-inﬂammatory eﬀects of this O3PUFA-
enriched diet were evident by a signiﬁcant reduction in
levels of inﬂammatory biomarkers, including cord
inositols and the phosphorylated p38 MAPK in dorsal
horn neurons.
Chronic neuropathic pain is a debilitating co-morbidity
associated with SCI and persists even at the later stages
of recovery and rehabilitation. This condition often
manifests as evoked pain, including hyperalgesia
(ampliﬁed pain response to noxious stimuli) and/or
allodynia (painful response to innocuous stimuli). The
intensity and frequency of neuropathic pain are
particularly inﬂuenced by trauma-induced neurochemical
and neuroanatomical changes in synaptic circuitry and
dorsal horn neuron hyperexcitability (Crown et al., 2008;
Gwak et al., 2009, 2010). Current approaches to treat
neuropathic pain include behavioral, pharmacological,
and surgical modalities, however, none of these
interventions are regarded as highly eﬀective. This could
be partly due to patients being treated after
considerable and perhaps irreversible changes have
developed. There is thus a need to develop preventive
approaches to build resilience to damage.
Complementary with current strategies, this type of
approach may be particularly important in individuals at
high risk of traumatic injuries like those actively
participating in contact sports, selected surgeries, ﬁrst
responders, and our men and women in the military
Fig. 9. Dietary O3PUFA-pretreatment reduces nociceptive ﬁber sprouting following chronic SCI. (A) Double-labeled spinal cord section showing
calcitonin gene-related peptide (CGRP) and growth-associated protein 43 (GAP43) immunoreactivity (IR) in spinal cord. Confocal photomicro-
graphs showing CGRP (B) and GAP43 (C) immunoreactivity in control chow-fed rat. Images were merged to quantify the immunoreactivity of
CGRP-containing sprouting aﬀerent ﬁbers (D). Optical density was most intense in laminae I to III of the dorsal horns. Sections were
morphometrically analyzed using stereological methods after thresholding binary images using ImageJ software (E). Representative image from
CGRP (F) and GAP43 (G) immunoreactivity in an animal fed O3PUFA-enriched diets. Merged (H) and binary (I) images depict CGRP-containing
GAP43+ ﬁbers in the dorsal horn (H). Boxes represent areas showing colocalization. Scale bar = 100 lm. (I) Results from quantiﬁcation of binary
particle counts of dorsal horn superﬁcial laminae. Analysis showed that O3PUFA-enriched diet signiﬁcantly reduced the colocalization of GAP43
and CGRP, suggesting a reduction in nociceptive ﬁber sprouting. Bars represent means ± standard error of the mean; Mann–Whitney U test
⁄p< 0.05, n= at least 4 rats.
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treat chronic neuropathic pain is supported by studies
showing that central pain can be prevented by pre-
administration of opiates (Dickenson and Sullivan,
1987), anti-inﬂammatory molecules (Plunkett et al.,
2001), or by prophylactic cell transplantation strategies
(Brewer and Yezierski, 1998; Yu et al., 1998). Although
it may seem unreasonable to use these approaches in
individuals undergoing SCI due to potential and
unwanted side eﬀects, prophylactic treatment with
dietary O3PUFAs oﬀers an excellent proﬁle of clinical
safety and may be beneﬁcial in preventing pain and
dysesthesias in individuals at risk (Bays, 2006; Mayer
et al., 2006).
O3PUFAs, such as docosahexaenoic acid (DHA) and
eicosapentaenoic acid (EPA), are ubiquitous lipid
messengers that regulate crucial neural processes in
health and disease. We recently reported that dietary
O3PUFAs exert a stringent control over phospholipid
production and are principal determinants of the cordlipid composition following chronic SCI (Figueroa et al.,
2013). Further, when the spinal cord is enriched with
O3PUFAs before SCI, these lipids mediate robust
neuroprotection, recovery, and activate pro-restorative
responses (Figueroa et al., 2012, 2013; Lim et al.,
2013). Several recent studies have shown the
importance of PUFAs in nociception, supporting
the hypothesis that dietary lipids are key elements of
the nociceptive pathways (Yehuda and Carasso, 1993;
Nakamoto et al., 2010; Xu et al., 2010; Tokuyama and
Nakamoto, 2011; Veigas et al., 2011). Consistent with
this idea, the present study shows that consumption of
a diet rich in O3PUFAs produces signiﬁcant thermal
anti-hyperalgesia when compared to animals receiving
control diets after contusion SCI. In contrast, thoracic
contusion to the cord resulted in a signiﬁcant reduction
in below-level thermal withdrawal latencies in animals
receiving control chow. Importantly, we reported that
control-fed injured rats exhibited signiﬁcant sensory
deﬁcits to mechanical stimulation on their hindpaws
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discard the idea that thermal hyperalgesia was due to a
hyperreﬂexic responses, a common occurrence in
contusive SCI (Christensen and Hulsebosch, 1997a).
This observation further suggests that both
neurodegenerative and pro-inﬂammatory responses may
play important roles in the development of neuropathic
pain after SCI (Krassioukov et al., 1999; Baumga¨rtner
et al., 2002).
Several lines of evidence demonstrate that the level of
spinal cord damage plays signiﬁcant roles in the
development and maintenance of pain-like behaviors
(Lindsey et al., 2000; Yezierski, 2000; Park et al., 2007),
suggesting that pain may be amenable to
neuroprotective approaches. In agreement with others,
evidence from our lab has shown that O3PUFAs confer
potent neuroprotection against SCI (Figueroa et al.,
2012, 2013). Together, these data suggest that
neuroprotection may be an underlying mechanism
involved in the anti-nociceptive responses mediated by
the dietary O3PUFAs. However, neuroprotective
approaches do not always result in anti-nociceptive
responses (Mills et al., 2002). We found comparable
open-ﬁeld locomotor scores when animals were grouped
based on their thermal withdrawal phenotypes. While
neurodegenerative diﬀerences between clusters may be
subtle or undetectable as measured by the BBB
locomotor scores, we interpret this ﬁnding as evidence
supporting additional underlying causes of neuropathic
pain.
The neurometabolomic etiology of neuropathic pain
remains poorly understood and this gap in the literature
has limited the development of eﬀective therapeutics. N-
acylated ethanolamines (NAE) and related
endocannabinoids (eCBs) are a large class of naturally
occurring lipids that exhibit diverse bioactivities,
including neuroprotective (Jackson et al., 2005) and
antinociceptive (Beltramo et al., 2006; Petrosino et al.,
2007; Hama and Sagen, 2011) responses. Notably, it
has been shown that SCI rats exhibit profound
alterations in the metabolic pathways associated with
these lipids (Garcia-Ovejero et al., 2009). These lipids
are produced on demand from membrane phospholipids
and glycerophospho-linked precursors by a series of
intracellular enzymatic reactions, followed by immediate
signaling and metabolism (Berger et al., 2001; Artmann
et al., 2008; Wang and Ueda, 2009; Banni and Di
Marzo, 2010; Wood et al., 2010; Brown et al., 2012).
The ﬁndings reported in the present study support and
expand on these observations by showing that chronic
SCI results in a marked deregulation in the metabolic
pathways of NAEs and related eCBs. In particular, we
found reduced levels of palmitoyl ethanolamine (PEA) in
the chronically injured cord, which were correlated with
hyperalgesic behaviors in SCI rats. PEA has been
implicated in anti-inﬂammatory responses and functional
recovery after SCI (Genovese et al., 2008; Esposito
et al., 2011; Esposito and Cuzzocrea, 2012) and
reduces pain-like behaviors in experimental models of
neuropathic pain (Costa et al., 2008; Buczynski et al.,
2010). Notably, dietary prophylaxis with O3PUFAssustained the levels of PEA after SCI. Further, the
O3PUFA-derived NAEs identiﬁed in this study are
precursors of docosahexaenoyl ethanolamine (DHEA;
synaptamide) and eicosapentaenoyl ethanolamine
(EPEA), which bind to cannabinoid receptors in rats
(Sheskin et al., 1997) and may contribute to the
beneﬁcial eﬀects mediated by dietary O3PFAs (Balvers
et al., 2010; Meijerink et al., 2011; Shinohara et al.,
2012). Although the metabolic pathways involved in
NAE biosynthesis remain unclear, our results strongly
suggest that NAPE-PLD-independent (N-acyl
phosphatidyl ethanolamine phospholipase D) pathways
are activated in chronic SCI and represent a promising
therapeutic target (Tsuboi et al., 2013). Because NAEs
can modify the response to nociceptive stimuli and are
tightly regulated by diet, O3PUFAs could have important
implications for chronic pain management.
There is now strong evidence linking the
neuroinﬂammatory milieu after SCI to changes in
sensory electrical activity and pain-related behaviors
(Hulsebosch, 2008). For instance, accumulating
evidence implicates the activation of the spinal p38
mitogen-activated protein kinase, p38 MAPK, as a
molecular mechanism underlying neuronal
hyperexcitability and pain after SCI (Crown et al., 2006,
2008; Gwak et al., 2009). Remarkably, animals
consuming dietary O3PUFAs exhibited reduced
numbers of dorsal neurons expressing p-p38, indicating
a potential molecular link between dietary lipids and
pain. This ﬁnding is supported by studies demonstrating
that both DHA and EPA alone attenuate the activation
of p38 in endothelial cells stimulated by TNF-a (Xue
et al., 2006). More recent studies showed that DHA also
impairs p38 MAPK signaling in microglial cultures
(Antonietta Ajmone-Cat et al., 2012). In agreement with
these ﬁndings on the potential anti-inﬂammatory and
antinociceptive roles of dietary O3PUFAs, this study
shows a marked reduction in the levels of inositols and
CGRP-positive sprouting ﬁbers in the chronically injured
cord. Importantly, the p38 MAPK has been linked to the
regulation of inositol levels in human peripheral blood
monocytes and macrophages (Denkert et al., 1998) and
to the expression of calcitonin gene-related peptide in
rats (Wang et al., 2011). This study supports the
dynamic interplay among these biomarkers of the
nociceptive system. Further studies are necessary to
evaluate these molecular interactions and to investigate
their potential as useful biomarkers to discriminate pain
severity in SCI-related neuropathic pain.
Although experimental contusion SCI is a well-
established and validated animal model for evaluating
the development of pain and analgesic strategies
(Resnick et al., 2004; DomBourian et al., 2006; Rajpal
et al., 2007; Cramer et al., 2008; Jung et al., 2008),
there are limitations in extrapolating ﬁndings from
experimental animal models and to humans. It has been
suggested that the mechanisms underlying evoked
responses in SCI animals may diﬀer from those of
underlying spontaneous neuropathic pain in patients
(Craig, 2009). The proper interpretation of animal pain-
like behaviors thus remains a challenge and warrants
J. D. Figueroa et al. / Neuroscience 255 (2013) 1–18 15further research. Given the signiﬁcant contribution of
supraspinal structures in pain processing (King et al.,
2003; Baastrup et al., 2010; Davoody et al., 2011),
futures studies should employ integrated pain-
associated behaviors to facilitate data interpretation and
to gain better understanding of the antinociceptive
targets of dietary O3PUFAs.Conclusions
In summary, this study shows for the ﬁrst time that dietary
O3PUFAs prophylaxis attenuates the development of
thermal hyperalgesia following SCI, possibly by
providing a better bioavailability for anti-inﬂammatory
lipid mediators. Even though recent advances in pain
research suggest that combinatorial strategies to both
prevent and combat chronic neuropathic pain are a
feasible goal (Hama and Sagen, 2012), identifying
targets with the intention of preventing pain is an
enormous conceptual challenge that has so far stymied
drug discovery. The study presented herein supports
the use of preventive alternative approaches in
individuals at the risk of developing neuropathic pain
and identiﬁes diet as a potential risk factor for poor
outcome. Although further research is needed, our
ﬁndings have remarkable public health implications to
reduce the burden of pain, particularly in populations at
risk. Because dietary O3PUFAs are safe, well tolerated,
and confer robust protection against experimental SCI
they should be favored for early pain management in
human SCI.
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